论文部分内容阅读
目的:分析糖皮质激素+特布他林在慢阻肺急性加重期患者治疗中的临床效果。方法:随机选取2014年4月-2016年7月所在医院98例慢阻肺急性加重期患者,随机分组,2组均采用特布他林进行治疗,观察组患者在此基础上给予糖皮质激素(丙酸氟替卡松气雾剂),对2组患者临床治疗效果进行对比。结果:观察组临床总有效率(91.84%)高于对照组(73.47%),2组差异明显(P<0.05)。结论:糖皮质激素+特布他林临床治疗效果明显,能够显著改善患者临床症状,对急性加重期患者治疗意义重大。
Objective: To analyze the clinical effect of glucocorticoid + terbutaline on the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease. Methods: A total of 98 patients with COPD in our hospital from April 2014 to July 2016 were randomly selected and randomly divided into two groups. The two groups were treated with terbutaline. The patients in the observation group were given glucocorticoid (Fluticasone propionate aerosol), the clinical efficacy of two groups of patients were compared. Results: The total clinical effective rate (91.84%) in the observation group was higher than that in the control group (73.47%). There was significant difference between the two groups (P <0.05). Conclusion: The clinical effect of glucocorticoids + terbutaline is obvious, which can significantly improve the clinical symptoms of patients and is of great significance to the treatment of patients with acute exacerbation.